Bendazac lysine dihydrate
- Level
- Commodity
- Parent
- 51384600
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51384623This classification denotes the lysine-dihydrate form of a nonsteroidal antiinflammatory drug with the molecular formula C16H14N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier G4AG71204O, chemically known as acetic acid, ((1-(phenylmethyl)-1h-indazol-3-yl)oxy)- but more generally known as bendazac, which bears US NIH Compound Identifier 2313. Bendazac most often comes in base, lysine, methyl ester, and sodium forms. European Medicines Agency schedules Bendazac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05708MIG. The term BENDAZAC is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 24, No. 11 1970, List 10). World Health Organization schedules bendazac in its Anatomical Therapeutic Chemical (ATC) Classification. BENDAZAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule bendazac lysine dihydrate under HS 29339990. As of Q4 2014, BENDAZAC LYSINE DIHYDRATE remains US FDA's Preferred Term for this commodity. SMILES: C1CCC(CC1)CN2C3CCCCC3C(N2)OCC(=O)O.C(CCN)C[C@@H](C(=O)O)N.O.O.
Same parent
Under 51384600 · 33Activities that produce or sell this
KBLI · 9Inherited from family 51380000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.